Search research articles
Contact Us
Filters
Showing results (171-180 of 214) with videos related to
Page
of 22
Sort By:
Cells
|
April 3, 2021
Constitutive Cell Proliferation Regulating Inhibitor of Protein Phosphatase 2A (CIP2A) Mediates Drug Resistance to Erlotinib in an EGFR Activating Mutated NSCLC Cell Line
Hisham Saafan, Ahmad Alahdab, Robin Michelet, et al.
Cells
|
April 25, 2025
Artesunate Inhibits Metastatic Potential in Cisplatin-Resistant Bladder Cancer Cells by Altering Integrins
Olesya Vakhrusheva, Fuguang Zhao, Sascha Dennis Markowitsch, et al.
Communications Biology
|
June 26, 2020
SAMHD1 is a key regulator of the lineage-specific response of acute lymphoblastic leukaemias to nelarabine
Tamara Rothenburger, Katie-May McLaughlin, Tobias Herold, et al.
Cells
|
October 5, 2019
Intact-Cell MALDI-ToF Mass Spectrometry for the Authentication of Drug-Adapted Cancer Cell Lines
Jane F Povey, Emily Saintas, Adewale V Aderemi, et al.
Biochemical Pharmacology
|
August 25, 2009
Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines
Martin Michaelis, Malte C Kleinschmidt, Susanne Barth, et al.
Cancers
|
March 6, 2021
Shikonin Reduces Growth of Docetaxel-Resistant Prostate Cancer Cells Mainly through Necroptosis
Sascha D Markowitsch, Kira M Juetter, Patricia Schupp, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
November 13, 2013
A systems pharmacology approach to improve drug therapy in NSCLC: establishing a CESAR network
Ganna V Kalayda, Martin Michaelis, Jindrich Cinatl, et al.
Translational Oncology
|
January 28, 2014
Testing of SNS-032 in a Panel of Human Neuroblastoma Cell Lines with Acquired Resistance to a Broad Range of Drugs
Nadine Löschmann, Martin Michaelis, Florian Rothweiler, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
November 14, 2013
NSCLC cells adapted to EGFR inhibition accumulate EGFR interacting proteins and down-regulate microRNA related to epithelial-mesenchymal transition
Robert M Mader, Sarah Foerster, Navin Sarin, et al.
Biomaterials
|
December 25, 2009
Enhanced drug targeting by attachment of an anti alphav integrin antibody to doxorubicin loaded human serum albumin nanoparticles
Sylvia Wagner, Florian Rothweiler, Marion G Anhorn, et al.
Page
of 22
Search research articles
Search
Showing results (171-180 of 214) with videos related to
Sort By:
Page
of 22
Cells
|
April 3, 2021
Constitutive Cell Proliferation Regulating Inhibitor of Protein Phosphatase 2A (CIP2A) Mediates Drug Resistance to Erlotinib in an EGFR Activating Mutated NSCLC Cell Line
Hisham Saafan, Ahmad Alahdab, Robin Michelet, et al.
Cells
|
April 25, 2025
Artesunate Inhibits Metastatic Potential in Cisplatin-Resistant Bladder Cancer Cells by Altering Integrins
Olesya Vakhrusheva, Fuguang Zhao, Sascha Dennis Markowitsch, et al.
Communications Biology
|
June 26, 2020
SAMHD1 is a key regulator of the lineage-specific response of acute lymphoblastic leukaemias to nelarabine
Tamara Rothenburger, Katie-May McLaughlin, Tobias Herold, et al.
Cells
|
October 5, 2019
Intact-Cell MALDI-ToF Mass Spectrometry for the Authentication of Drug-Adapted Cancer Cell Lines
Jane F Povey, Emily Saintas, Adewale V Aderemi, et al.
Biochemical Pharmacology
|
August 25, 2009
Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines
Martin Michaelis, Malte C Kleinschmidt, Susanne Barth, et al.
Cancers
|
March 6, 2021
Shikonin Reduces Growth of Docetaxel-Resistant Prostate Cancer Cells Mainly through Necroptosis
Sascha D Markowitsch, Kira M Juetter, Patricia Schupp, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
November 13, 2013
A systems pharmacology approach to improve drug therapy in NSCLC: establishing a CESAR network
Ganna V Kalayda, Martin Michaelis, Jindrich Cinatl, et al.
Translational Oncology
|
January 28, 2014
Testing of SNS-032 in a Panel of Human Neuroblastoma Cell Lines with Acquired Resistance to a Broad Range of Drugs
Nadine Löschmann, Martin Michaelis, Florian Rothweiler, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
November 14, 2013
NSCLC cells adapted to EGFR inhibition accumulate EGFR interacting proteins and down-regulate microRNA related to epithelial-mesenchymal transition
Robert M Mader, Sarah Foerster, Navin Sarin, et al.
Biomaterials
|
December 25, 2009
Enhanced drug targeting by attachment of an anti alphav integrin antibody to doxorubicin loaded human serum albumin nanoparticles
Sylvia Wagner, Florian Rothweiler, Marion G Anhorn, et al.
Page
of 22